Caterina Serra

Caterina Serra

Auto-generated profile, based on publicly available information

Caterina Serra


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 February 2020 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
RPRossella Porcheddu
Rossella Porcheddu
CSCaterina Serra
Caterina Serra
DKDavid Kelvin
David Kelvin
NKNikki Kelvin
Nikki Kelvin
SRSalvatore Rubino
Salvatore Rubino
As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.

Verified
Journal Article
Open access
PDF file
ADAntonina Dolei
Antonina Dolei
GIGabriele Ibba
Gabriele Ibba
CPClaudia Piu
Claudia Piu
CSCaterina Serra
Caterina Serra
Human endogenous retroviruses (HERVs) are genetic parasites, in-between genetics and environment. Few HERVs retain some coding capability. Sometimes, the host has the advantage of some HERV genes; conversely, HERVs may contribute to pathogenesis. The expression of HERVs depends on several factors, and is regulated epigenetically by stimuli such as inflammation, viral and microbial infections, etc. Increased expression of HERVs occurs in physiological and pathological conditions, in one or more body sites. Several diseases have been attributed to one or more HERVs, particularly neurological diseases. The key problem is to differentiate the expression of a HERV as cause or effect of a disease. To be used as a biomarker, a correlation between the expression of a certain HERV and the disease onset and/or behavior must be found. The greater challenge is to establish a pathogenic role. The criteria defining causal connections between HERVs and diseases include the development of animal models, and disease modulation in humans, by anti-HERV therapeutic antibody. So far, statistically significant correlations between HERVs and diseases have been achieved for HERV-W and multiple sclerosis; disease reproduction in transgenic animals was achieved for HERV-W and multiple sclerosis, and for HERV-K and amyotrophic lateral sclerosis. Clinical trials for both diseases are in progress.

Verified
Journal Article
Open access
PDF file
Andrea AngiusAndrea Angius
Andrea Angius
PUPaolo Uva
Paolo Uva
GPGiovanna Pira
Giovanna Pira
MMMaria Rosaria Muroni
Maria Rosaria Muroni
Giovanni SotgiuGiovanni Sotgiu
Giovanni Sotgiu
Maria Rosaria De MiglioMaria Rosaria De Miglio
Maria Rosaria De Miglio
Colorectal cancer (CRC) ranks as the most frequent carcinoma worldwide. CRC patients show strong prognostic differences and responses to treatment, and 20% have incurable metastatic disease at diagnosis. We considered it essential to investigate mechanisms that control cellular regulatory networks, such as the miRNA–mRNA interaction, known to be involved in cancer pathogenesis. We conducted a human miRNome analysis by TaqMan low density array, comparing CRC to normal colon tissue (NCT, and experimentally identified gene targets of miRNAs deregulated, by anti-correlation analysis, with the CRC whole-transcriptome profile obtained from RNASeq experiments. We identified an integrated signature of 20 deregulated miRNAs in CRC. Enrichment analyses of the gene targets controlled by these miRNAs brought to light 25 genes, members of pathways known to lead to cell growth and death (CCND1, NKD1, FZD3, MAD2L1, etc.), such as cell metabolism (ACSL6, PRPS1-2). A screening of prognosis-mediated miRNAs underlined that the overexpression of miR-224 promotes CRC metastasis, and is associated with high stage and poor survival. These findings suggest that the biology and progression of CRC depend on deregulation of multiple miRNAs that cause a complex dysfunction of cellular molecular networks. Our results have further established miRNA–mRNA interactions and defined multiple pathways involved in CRC pathogenesis.

7 August 2018 in Viruses
Verified
Journal Article
Open access
PDF file
GIGabriele Ibba
Gabriele Ibba
CPClaudia Piu
Claudia Piu
EUElena Uleri
Elena Uleri
CSCaterina Serra
Caterina Serra
ADAntonina Dolei
Antonina Dolei
The human endogenous retrovirus (HERV)-K, human mouse mammary tumor virus like-2 (HML-2) subgroup of HERVs is activated in several tumors and has been related to prostate cancer progression and motor neuron diseases. The cellular splicing factor 2/alternative splicing factor (SF2/ASF) is a positive regulator of gene expression, coded by a potent proto-oncogene, amplified, and abnormally expressed in tumors. TAR DNA-binding protein-43 (TDP-43) is a DNA/RNA-binding protein, negative regulator of alternative splicing, known for causing neurodegeneration, and with complex roles in oncogenesis. We used the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology, with the Cas9 system from Staphylococcus aureus (SaCas9), to disrupt the HERV-K(HML-2)env gene, and evaluated the effects on cultured cells. The tool was tested on human prostate cancer LNCaP cells, whose HERV-Kenv transcription profile is known. It caused HERV-K(HML-2)env disruption (the first reported of a HERV gene), as evaluated by DNA sequencing, and inhibition of env transcripts and proteins. The HERV-K(HML-2)env disruption was found to interfere with important regulators of cell expression and proliferation, involved in manaling, RNA-binding, and alternative splicing, such as epidermal growth factor receptor (EGF-R), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), SF2/ASF, and TDP-43. These novel findings suggest that HERV-K is not an innocent bystander, they reinforce its links to oncogenesis and motor neuron diseases, and they open potential innovative therapeutic options.

1 December 2003
Verified
Journal Article
Closed access
CSCaterina Serra
Caterina Serra
GMGiuseppe Mameli
Giuseppe Mameli
GAGiannina Arru
Giannina Arru
Stefano SotgiuStefano Sotgiu
Stefano Sotgiu
GRGiulio Rosati
Giulio Rosati
ADAntonina Dolei
Antonina Dolei
Multiple sclerosis (MS)-associated retrovirus (MSRV) is a component of the human endogenous retrovirus (HERV)-W family, with gliotoxic and superantigenic properties, related to MS clinical progression, and transactivated by viral agents. The authors studied MSRV modulation by cytokines involved in vivo in MS course, utilizing peripheral blood mononuclear cells from MSRV-positive and MRSV-negative individuals. Cultured cells from MSRV-negative subjects did not produce virus, whereas spontaneous MSRV release was detected in cultures from MSRV-positive donors; virus release was increased by interleukin (IL)-4 and IL-6 and, to a greater extent, by the detrimental cytokines interferon gamma and tumor necrosis factor (TNF)alpha. Interferon beta, used in MS therapy, inhibits MSRV release. A parallel between the effects of these cytokines on MSRV production in vitro and on MS disease in vivo is observed, which deserves further elucidations.

1 February 2008 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
CSCaterina Serra
Caterina Serra
ABAdriana Biolchini
Adriana Biolchini
AMAlessandra Mei
Alessandra Mei
SKSergei Kotenko
Sergei Kotenko
ADAntonina Dolei
Antonina Dolei
The newly discovered type III interferon λ (IFN-λ) has antiviral activity against a broad spectrum of viruses and potent immune-related activities. Its major producers are peripheral blood mononuclear cells (PBMCs) and dendritic cells. The above functions and cells are deeply involved in AIDS pathogenesis, but there is no information so far on IFN-λ effects on HIV. Therefore we addressed the sensitivity of HIV-1 replication to cell exposure to human IFN-λ2. Human PBMCs and C8166 T cells were treated with human Type III or Type I IFNs, and the ability of HIV-1 to bind and replicate in untreated and IFN-treated cells was investigated. Virus amounts were quantified by infectivity and p24 assays. In parallel, we evaluated the possible antiproliferative effects of IFN-λ2 and the expression of CD4, CXCR4, and CCR5 genes, whose transcripts were quantified by real time RT-PCR. Data showed increased adsorption of HIV to IFN-treated cells in a dose-dependent fashion. Virus yields increased accordingly. In both systems the accumulation of CD4, CXCR4, and CCR5 transcripts was increased, particularly in PBMCs. Antiproliferative activity and classical antiviral state were instead detected on PBMCs, but not on C8166 cells. We concluded that pretreatment of PBMCs and C8166 cells with Type III and Type I IFNs causes increased HIV binding and replication. These effects are likely to be due to increased expression of HIV receptors and coreceptors on the plasma membrane. These findings indicate another mechanism utilized by HIV for subversion of host defenses.